title: Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial.
authors: Duke Clinical Research Institute, Durham, North Carolina 27715, USA. alkha001@mc.duke.edu
authors: S M
authors: SM
authors: Al-Khatib
authors: K S
authors: KS
authors: Pieper
authors: K L
authors: KL
authors: Lee
authors: K W
authors: KW
authors: Mahaffey
authors: J S
authors: JS
authors: Hochman
authors: C J
authors: CJ
authors: Pepine
authors: S L
authors: SL
authors: Kopecky
authors: M
authors: M
authors: Akkerhuis
authors: J
authors: J
authors: Stepinska
authors: M L
authors: ML
authors: Simoons
authors: E J
authors: EJ
authors: Topol
authors: R M
authors: RM
authors: Califf
authors: R A
authors: RA
authors: Harrington
mesh_terms: D001281:Atrial Fibrillation / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality*; D004311:Double-Blind Method; D000077542:Eptifibatide; D005260:Female; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000150:complications* / Q000188:drug therapy; D010455:Peptides / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D016016:Proportional Hazards Models; D020521:Stroke / Q000209:etiology / Q000401:mortality; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide